Fusobacterium nucleatum upregulates the immune inhibitory receptor PD-L1 in colorectal cancer cells via the activation of ALPK1
Fusobacterium nucleatum is a Gram-negative oncobacterium that is associated with colorectal cancer. The molecular mechanisms utilized by F. nucleatum to promote colorectal tumor development have largely focused on adhesin-mediated binding to the tumor tissue and on the pro-inflammatory capacity of F...
Saved in:
Main Authors: | Coco Duizer, Moniek Salomons, Merel van Gogh, Sanne Gräve, Freke A. Schaafsma, Maaike J. Stok, Merel Sijbranda, Raghuvandhanan Kumarasamy Sivasamy, Rob J. L. Willems, Marcel R. de Zoete |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2025-12-01
|
Series: | Gut Microbes |
Subjects: | |
Online Access: | https://www.tandfonline.com/doi/10.1080/19490976.2025.2458203 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Commensalism of Fusobacterium nucleatum - The dilemma
by: Sangeeta Nayak, et al.
Published: (2024-07-01) -
Comparative analysis of the primary structure and production of recombinant poly(ADP-ribose)polymerase 1 of long-lived Heterocephalus glaber
by: K. N. Naumenko, et al.
Published: (2024-11-01) -
Ethanolamine-induced assembly of microcompartments is required for Fusobacterium nucleatum virulence
by: Dana S. Franklin, et al.
Published: (2025-02-01) -
Intratumoral <i>Fusobacterium nucleatum</i> in Pancreatic Cancer: Current and Future Perspectives
by: Domenica Lucia D’Antonio, et al.
Published: (2024-12-01) -
The Role of Oral Fusobacterium nucleatum in Female Breast Cancer: A Systematic Review and Meta-Analysis
by: Fariah I. Gaba, et al.
Published: (2022-01-01)